scholarly article | Q13442814 |
P356 | DOI | 10.1099/0022-1317-74-11-2391 |
P8608 | Fatcat ID | release_hebeci7byfcexekowwpp6fp3nm |
P3181 | OpenCitations bibliographic resource ID | 1943695 |
P698 | PubMed publication ID | 8245854 |
P5875 | ResearchGate publication ID | 14953145 |
P50 | author | Edward C. Holmes | Q28152069 |
Peter Simmonds | Q28379677 | ||
P2093 | author name string | Chan SW | |
Kolberg J | |||
Yap PL | |||
McOmish F | |||
Urdea MS | |||
Irvine B | |||
Cha TA | |||
Beall E | |||
P407 | language of work or name | English | Q1860 |
P921 | main subject | virus | Q808 |
hepatitis C | Q154869 | ||
Hepatitis C virus | Q708693 | ||
phylogenetics | Q171184 | ||
P304 | page(s) | 2391-2399 | |
P577 | publication date | 1993-11-01 | |
P1433 | published in | Journal of General Virology | Q6295245 |
P1476 | title | Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region | |
P478 | volume | 74 ( Pt 11) |
Q42983299 | A DNA hybridization method for typing hepatitis C virus genotype 2c. |
Q25255565 | A general method for nested RT-PCR amplification and sequencing the complete HCV genotype 1 open reading frame |
Q44988872 | A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C. |
Q27469343 | A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. |
Q57205742 | A proposed system for the nomenclature of hepatitis C viral genotypes |
Q33855490 | A retrospective overview of enterovirus infection diagnosis and molecular epidemiology in the public hospitals of Marseille, France (1985-2005). |
Q33256564 | A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users |
Q33997485 | A serotyping assay for hepatitis C virus in Southeast Asia |
Q43001849 | A shift in the Hepatitis C virus genotype dominance in blood donor samples from Thailand |
Q57208129 | Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients |
Q27485690 | Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology |
Q27473009 | Acute hepatitis C infection after sexual exposure. |
Q42999261 | Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus |
Q27469375 | Alterations to both the primary and predicted secondary structure of stem-loop IIIc of the hepatitis C virus 1b 5' untranslated region (5'UTR) lead to mutants severely defective in translation which cannot be complemented in trans by the [...] |
Q39154271 | Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle. |
Q42983592 | An in-house method for the detection and quantification of HCV in serum samples using a TaqMan assay real time PCR approach |
Q37095842 | An increased diversity of HCV isolates were characterized among 393 patients with liver disease in China representing six genotypes, 12 subtypes, and two novel genotype 6 variants |
Q37719516 | An overview about hepatitis C: a devastating virus |
Q34916120 | An overview of HCV molecular biology, replication and immune responses |
Q43035780 | Analysis of 5' non-coding region in hepatitis C virus by single-strand conformation polymorphism and low-stringency single specific primer PCR. |
Q73629650 | Analysis of biochemical and virological efficacy of human lymphoblastoid interferon (IFN) in patients with compensated type C liver cirrhosis: comparative study between increase in individual IFN dose and prolonging of treatment period, using a mult |
Q27487891 | Analysis of hepatitis C virus isolates among healthy blood donors and drug addicts in Chiang Mai, Thailand |
Q47314419 | Analysis of naturally occurring resistance-associated variants to NS3/4A protein inhibitors, NS5A protein inhibitors and NS5B polymerase inhibitors in patients with chronic hepatitis C. |
Q36679489 | Analysis of the core and E1 envelope region sequences of a novel variant of hepatitis C virus obtained in Indonesia |
Q43041953 | Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies |
Q34545880 | Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules. |
Q43046988 | Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination |
Q42996637 | Apparent epidemic of HCV infection in a haemodialysis unit |
Q27469409 | Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs |
Q33617717 | Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population |
Q43048778 | Association of HLA Alleles with Response (Especially Biochemical Response) to Interferon Therapy in Japanese Patients with Chronic Hepatitis C |
Q34484305 | Association of genetic variations in GNB1 with response to peginterferon plus ribavirin therapy for chronic hepatitis C in a Chinese population in Taiwan |
Q43046674 | Association of hepatitis C virus NS5B variants with resistance to new antiviral drugs among untreated patients |
Q44654522 | Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation |
Q37313166 | Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection |
Q40459443 | Bioinformatic Analysis of Codon Usage and Phylogenetic Relationships in Different Genotypes of the Hepatitis C Virus. |
Q41712075 | Biological dynamics of viral load in hemodialysis patients with hepatitis C virus |
Q33631104 | Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance |
Q27473535 | CD4+/CD8+ ratio of liver-derived lymphocytes is related to viraemia and not to hepatitis C virus genotypes in chronic hepatitis C |
Q45609955 | CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection |
Q54231580 | CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells. |
Q43037126 | CD81 expression for discrimination between sustained virologic response and relapse in patients with chronic hepatitis C. |
Q34140014 | Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models |
Q43032801 | Change in hepatitis C virus clades: a cross-sectional study of chronic HCV patients in Pakistan from 2000-2010. |
Q42980301 | Changes in hepatitis C virus quasispecies and density populations in patients before and after interferon therapy |
Q43040009 | Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. |
Q35920144 | Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china |
Q37602315 | Characterisation of hepatitis C virus genotype among blood donors at the regional blood transfusion centre of Ouagadougou, Burkina Faso |
Q35141727 | Characteristics of HCV co-infection among HIV infected individuals from an area with high risk of blood-borne infections in central China. |
Q42987930 | Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa |
Q40815800 | Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes |
Q40831393 | Characterization of partial NS5B region among hepatitis C virus genotype 6 subtypes isolated from Thai blood donors |
Q42986489 | Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels |
Q48724304 | Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989;244:359-362]. |
Q43047091 | Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease |
Q74529990 | Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis |
Q43038265 | Classification of hepatitis C virus into major types and subtypes based on molecular evolutionary analysis |
Q35834810 | Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes |
Q35059546 | Classifying genotype F of hepatitis B virus into F1 and F2 subtypes |
Q39977681 | Clearance of HCV by Combination Therapy of Pegylated Interferon alpha-2a and Ribavirin Improves Insulin Resistance |
Q27473463 | Clinical Evaluation of Two Methods for Genotyping Hepatitis C Virus Based on Analysis of the 5' Noncoding Region |
Q36756371 | Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6 |
Q31054551 | Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients. |
Q73114557 | Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States |
Q27477946 | Clinical guidelines on the management of hepatitis C |
Q42983646 | Clinical implications of GBV-C/HGV infection in patients with "HCV-related" chronic hepatitis |
Q24514512 | Clinical significance of hepatitis C virus genotypes |
Q36150271 | Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs |
Q41841986 | Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy |
Q27480736 | Cold-Temperature Plastic Resin Embedding of Liver for DNA- and RNA-Based Genotyping |
Q43048751 | Comparative analysis of viral titers and histologic features of Pakistani patients infected with hepatitis C virus type 3. |
Q35505377 | Comparative performance evaluation of hepatitis C virus genotyping based on the 5' untranslated region versus partial sequencing of the NS5B region of brazilian patients with chronic hepatitis C. |
Q43048799 | Comparative study of different methods to genotype hepatitis C virus type 6 variants |
Q27485751 | Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients |
Q27473038 | Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5 |
Q27469399 | Comparison of DNA enzyme immunoassay and line probe assays (Inno-LiPA HCV I and II) for hepatitis C virus genotyping. |
Q36118779 | Comparison of Three Different Hepatitis C Virus Genotyping Methods: 5'NCR PCR-RFLP, Core Type-Specific PCR, and NS5b Sequencing in a Tertiary Care Hospital in South India. |
Q42996047 | Comparison of envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates |
Q37014659 | Comparison of hepatitis C viral loads in patients with or without coinfection with different genotypes |
Q43037312 | Comparison of line probe assay and DNA sequencing of 5' untranslated region for genotyping hepatitis C virus: description of novel line probe patterns |
Q43034268 | Comparison of real-time quantitative polymerase chain reaction with three other assays for quantitation of hepatitis C virus. |
Q43034846 | Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays |
Q27486386 | Complete genome of a European hepatitis C virus subtype 1g isolate: phylogenetic and genetic analyses |
Q27485775 | Concordance of hepatitis C virus typing methods based on restriction fragment length polymorphism analysis in 5' noncoding region and NS4 serotyping, but not in core PCR or a line probe assay |
Q27861119 | Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes |
Q38529929 | Construction of hepatitis C-SIN virus recombinants with replicative dependency on hepatitis C virus serine protease activity |
Q34552781 | Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response |
Q34604806 | Controversies in and challenges to our understanding of hepatitis C. |
Q38467109 | Core as a novel viral target for hepatitis C drugs |
Q64954537 | Core encoding sequences of Hepatitis C virus in Ghanaian blood donors are predominantly mosaics of different genotype 2 strains and cannot distinguish subtypes |
Q30757296 | Correlation between mutations in the interferon sensitivity-determining region of NS5A protein and viral load of hepatitis C virus subtypes 1b, 1c, and 2a |
Q42986317 | Correlation between relative number of circulating low-density hepatitis C virus particles and disease activity in patients with chronic hepatitis C. |
Q42989115 | Correlation between virus genotype and chronicity rate in acute hepatitis C. |
Q37142229 | Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients |
Q33826033 | Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects |
Q33811619 | Cryoglobulinemia |
Q74514123 | Cryoglobulinemia due to chronic viral hepatitis infections is not a major problem in clinical practice |
Q42990339 | Cryoglobulins and cryoglobulinemia. Diagnostic and therapeutic considerations |
Q37884087 | Current drug discovery strategies for treatment of hepatitis C virus infection |
Q37201846 | Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems |
Q27469625 | De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus |
Q45738503 | Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as a predictor of the efficacy of therapy |
Q42990146 | Degree and distribution of variability in the 5' untranslated, E1, E2/NS1 and NS5 regions of the hepatitis C virus (HCV). |
Q36192394 | Demographic characteristics and intravenous drug use among hepatitis C patients in the Kota Setar district, Kedah, Malaysia |
Q42980131 | Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong |
Q43037481 | Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay |
Q34359266 | Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury |
Q42994592 | Detection of hepatitis C virus RNA by in situ hybridization in paraformaldehyde fixed biopsies |
Q43037677 | Detection of hepatitis C virus with RNA polymerase chain reaction in fulminant hepatic failure |
Q42986936 | Determination of HCV RNA concentration by direct quantitation of the products from a single RT-PCR. |
Q33962062 | Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. |
Q42998028 | Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assay |
Q27487022 | Development of Intergenotypic Chimeric Replicons To Determine the Broad-Spectrum Antiviral Activities of Hepatitis C Virus Polymerase Inhibitors |
Q39449520 | Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. |
Q38327430 | Diagnosis and Management of Hepatitis C Virus Infection |
Q60232505 | Diagnostic and clinical implications of the different genotypes of hepatitis C virus |
Q43031516 | Difference in quasispecies of the hypervariable region 1 of hepatitis C virus between alcoholic and non-alcoholic patients |
Q40942638 | Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response |
Q27485767 | Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular carcinoma in Surabaya, Indonesia |
Q34321440 | Direct-acting antiviral agents for hepatitis C virus infection |
Q35866972 | Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection |
Q42978750 | Discrepancy of hepatitis C virus genotypes as determined by phylogenetic analysis of partial NS5 and core sequences |
Q45751228 | Distinct genotypes of a nonenveloped DNA virus associated with posttransfusion non-A to G hepatitis (TT virus) in plasma and peripheral blood mononuclear cells |
Q42993720 | Distribution of HCV genotypes among different exposure categories in Brazil |
Q42978542 | Distribution of genotypes and response to alpha-interferon in patients with hepatitis C virus infection in Germany |
Q35649742 | Distribution of hepatitis C virus genotypes in Canada: Results from the LCDC Sentinel Health Unit Surveillance System |
Q39529255 | Distribution of hepatitis C virus genotypes in Chinese patients with chronic hepatitis C: correlation with patients' characteristics and clinical parameters |
Q42981820 | Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters. |
Q42982322 | Distribution of hepatitis C virus genotypes in Slovenia |
Q35080005 | Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study |
Q27487893 | Distribution of viral genotypes in Italy determined by hepatitis C virus typing by DNA immunoassay |
Q35010474 | Distribution pattern of HCV genotypes & its association with viral load. |
Q27485762 | Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors |
Q42995830 | Diversity of nucleotide sequences in hypervariable region 1 of hepatitis C virus in Japanese patients with chronic hepatitis C of unknown mode of transmission |
Q27485656 | Dynamic analysis of heterogeneous hepatitis C virus populations by direct solid-phase sequencing |
Q43000414 | Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy |
Q43038116 | Effect of hepatitis C genotype on mother-to-infant transmission of virus. |
Q42990180 | Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells. |
Q43000283 | Effect of interferon treatment on serum 2',5'-oligoadenylate synthetase levels in hepatitis C-infected patients |
Q42986058 | Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices |
Q34294938 | Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection |
Q39640069 | Efficacy and safety of telaprevir in patients with genotype 1 hepatitis C infection. |
Q43037670 | Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level |
Q30448796 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions |
Q56395674 | Epidemic history of hepatitis C virus genotypes and subtypes in Portugal |
Q36112907 | Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa |
Q27472758 | Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance |
Q35507630 | Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland |
Q77221647 | Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment |
Q42983274 | Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays |
Q27486402 | Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0 |
Q27473495 | Evaluation of a New Serotyping Assay for Detection of Anti-Hepatitis C Virus Type-Specific Antibodies in Serum Samples |
Q42998799 | Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systems |
Q43035190 | Evaluation of complete genome sequences and sequences of individual gene products for the classification of hepatitis C viruses |
Q35990080 | Evaluation of multiplex nested polymerase chain reaction for routine hepatitis C virus genotyping in egyptian patients |
Q27486902 | Evaluation of the TRUGENE HCV 5'NC Genotyping Kit with the New GeneLibrarian Module 3.1.2 for Genotyping of Hepatitis C Virus from Clinical Specimens |
Q42982618 | Evaluation of two simplified methods for genotyping hepatitis C virus |
Q42861856 | Evidence for action of ribavirin through the hepatitis C virus RNA polymerase |
Q34242504 | Evidence for separation of HCV subtype 1a into two distinct clades. |
Q27486806 | Evidence of Recombination in Intrapatient Populations of Hepatitis C Virus |
Q42992701 | Evidence of hepatitis C virus in cervical smears |
Q27490444 | Evidence of recombination in Hepatitis C Virus populations infecting a hemophiliac patient |
Q27477594 | Evidence of recombination in quasispecies populations of a Hepatitis C Virus patient undergoing anti-viral therapy |
Q27473437 | Evidence of structural genomic region recombination in Hepatitis C virus |
Q36931081 | Evidence of subtype-specific antibodies to antigenic epitopes in the NS5 region of hepatitis C virus in the circulation of patients with chronic hepatitis C. |
Q33865608 | Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses |
Q58701375 | Evolving Trends in the Hepatitis C Virus Molecular Epidemiology Studies: From the Viral Sequences to the Human Genome |
Q33557770 | Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment |
Q33682538 | Expanding allelic diversity of Helicobacter pylori vacA. |
Q24529494 | Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain |
Q35937788 | Expression of transforming growth factor beta-1 in chronic hepatitis and hepatocellular carcinoma associated with hepatitis C virus infection |
Q42986748 | Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence |
Q43039602 | Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only |
Q26822400 | Finally sofosbuvir: an oral anti-HCV drug with wide performance capability |
Q27485996 | Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses |
Q43036009 | Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages |
Q35040087 | Frequency distribution of HCV genotypes among chronic hepatitis C patients of Khyber Pakhtunkhwa |
Q27486226 | Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission |
Q43037218 | Frequent detection of hepatitis C virus subtype 3a (HCV-3a) isolates in Thailand by PCR using subtype-specific primers |
Q42692227 | Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward |
Q42999157 | Full-genome nucleotide sequence of a hepatitis C virus variant (isolate name VAT96) representing a new subtype within the genotype 2 (arbitrarily 2k). |
Q45772528 | Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus |
Q27473215 | Generation of Infectious Hepatitis C Virus in Immortalized Human Hepatocytes |
Q34577134 | Genetic and biochemical diversity in the HCV NS5B RNA polymerase in the context of interferon α plus ribavirin therapy |
Q38479346 | Genetic and phylogenetic analyses of hantaviral sequences amplified from archival tissues of deer mice (Peromyscus maniculatus nubiterrae) captured in the eastern United States |
Q40659243 | Genetic characterization of ruminant pestiviruses: sequence analysis of viral genotypes isolated from sheep |
Q36388411 | Genetic diversity and evolution of hepatitis C virus in the Latin American region |
Q24655361 | Genetic history of hepatitis C virus in East Asia |
Q42982537 | Genetic variability in the 5' UTR and NS5A regions of hepatitis C virus RNA isolated from non-responding and responding patients with chronic HCV genotype 1 infection |
Q42278785 | Genetic variation in NOS2A is associated with a sustained virological response to peginterferon plus ribavirin therapy for chronic hepatitis C in Taiwanese Chinese |
Q36601301 | Genome sequence of the hepatitis C virus subtype 6n isolated from malaysia. |
Q27487540 | Genome-wide hepatitis C virus amino acid covariance networks can predict response to antiviral therapy in humans |
Q27480295 | Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis |
Q40848400 | Genotype 3 is the predominant hepatitis C genotype in a multi-ethnic Asian population in Malaysia |
Q36826456 | Genotype analysis of hepatitis C virus among blood donors and inmates in Metro Manila, The Philippines |
Q42979026 | Genotype determination of hepatitis C virus from northern India: identification of a new subtype |
Q43037735 | Genotype distribution and comparison of the putative envelope region of hepatitis C virus from Korean patients |
Q43040122 | Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virus |
Q43035147 | Genotypes and virus load in patients with hepatitis C infection |
Q43034438 | Genotypic and epidemiologic characteristics of hepatitis C virus infections among recent injection drug user and nonuser populations |
Q27485781 | Genotypic distribution of hepatitis C virus in different regions of Thailand |
Q27485356 | Genotyping HIV-1 and HCV strains by a combinatorial DNA melting assay (COMA) |
Q27485737 | Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method |
Q27487882 | Genotyping of Canadian hepatitis C virus isolates by PCR |
Q41439594 | Genotyping of hepatitis B and C virus Russian isolates for reference serum panel construction |
Q27485654 | Genotyping of hepatitis C virus in South Africa |
Q27485754 | Genotyping of hepatitis C virus isolates from Lebanese hemodialysis patients by reverse transcription-PCR and restriction fragment length polymorphism analysis of 5' noncoding region |
Q42983530 | Genotyping of hepatitis C virus performed by type-specific PCR in comparison to nucleotide sequencing of NS5 and core regions |
Q27472740 | Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes |
Q27487786 | Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey |
Q36461735 | Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability |
Q27485672 | Greater diversity of hepatitis C virus genotypes found in Hong Kong than in mainland China |
Q39355216 | HBV and HCV chronic hepatitis and cirrhosis. |
Q37664059 | HCV drug discovery aimed at viral eradication |
Q34117848 | HCV genotype distribution and possible transmission risks in Lahore, Pakistan. |
Q39457679 | HCV genotypes among 1013 Saudi nationals: a multicenter study |
Q38903085 | HCV genotypes in Morocco |
Q42991121 | HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients. |
Q43930193 | HCV prevalence and co-infection with HIV among pregnant women in Saint Camille Medical Centre, Ouagadougou |
Q43048742 | HCV serotypes in Brazilian patients |
Q42978743 | HCV transmission in family members of subjects with HCV related chronic liver disease |
Q56001841 | HEPATITIS C |
Q27478341 | HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release |
Q42981045 | Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C. |
Q34103218 | Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients |
Q42984394 | Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia |
Q27490447 | Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice |
Q27490450 | Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes |
Q27486013 | Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral Therapy |
Q27477554 | Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3 |
Q37663438 | Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution |
Q26775815 | Hepatitis C genotype 4: The past, present, and future |
Q37073708 | Hepatitis C genotype 4: What we know and what we don't yet know. |
Q42981870 | Hepatitis C genotypes in Finland determined by RFLP. |
Q42985109 | Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up |
Q27469411 | Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission |
Q35076885 | Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype. |
Q40560378 | Hepatitis C updated |
Q37420620 | Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users |
Q27487926 | Hepatitis C virus (HCV) core serotypes in chronic HCV infection |
Q43040543 | Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region |
Q34215894 | Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepat |
Q27477979 | Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome |
Q42986448 | Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma |
Q36240052 | Hepatitis C virus (HCV) genotypes in the Caribbean island of Martinique: evidence for a large radiation of HCV-2 and for a recent introduction from Europe of HCV-4 |
Q27485684 | Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6 |
Q27486009 | Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics |
Q42132899 | Hepatitis C virus RNA: molecular switches mediated by long-range RNA-RNA interactions? |
Q42978470 | Hepatitis C virus amino acid sequence diversity correlates with the outcome of combined interferon/ribavirin therapy in Chinese patients with chronic hepatitis C. |
Q27482007 | Hepatitis C virus and lymphoma |
Q57295205 | Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development |
Q42988954 | Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover |
Q36797841 | Hepatitis C virus genetic variability in patients undergoing antiviral therapy |
Q42239862 | Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma. |
Q34503772 | Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan. |
Q27024231 | Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication |
Q27491345 | Hepatitis C virus genotype frequency in Isfahan province of Iran: a descriptive cross-sectional study |
Q42992110 | Hepatitis C virus genotypes among patients with lichen planus in the Kingdom of Saudi Arabia |
Q42989326 | Hepatitis C virus genotypes and clinical features in hepatitis C virus-related mixed cryoglobulinemia |
Q42980056 | Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia |
Q34522014 | Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan |
Q42221723 | Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy |
Q27488500 | Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006 |
Q43049282 | Hepatitis C virus genotypes in Hungarian and Austrian patients with chronic hepatitis C. |
Q35938587 | Hepatitis C virus genotypes in Korea and their relationship to clinical outcome in type C chronic liver diseases |
Q42979081 | Hepatitis C virus genotypes in blood donors and patients with chronic hepatitis C. |
Q41698449 | Hepatitis C virus genotypes in chronic hepatitis C patients and in first time blood donors in northeastern Bosnia and Herzegovina |
Q41958799 | Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome |
Q42985123 | Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation |
Q43031825 | Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe |
Q27472749 | Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b |
Q27472594 | Hepatitis C virus heteroduplex tracking assay for genotype determination reveals diverging genotype 2 isolates in Italian hemodialysis patients |
Q43037861 | Hepatitis C virus infection among Brazilian hemophiliacs: a virological, clinical and epidemiological study. |
Q27490176 | Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection |
Q41398433 | Hepatitis C virus infection in dialysis and renal transplantation |
Q42994116 | Hepatitis C virus infection in four haemodialysis units of southern Italy: epidemiological report |
Q27469600 | Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding |
Q26853500 | Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy |
Q27472905 | Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses |
Q27486393 | Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa |
Q24517933 | Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies |
Q42981262 | Hepatitis C virus subtype 3b infection in a hospital in Japan: epidemiological study |
Q42270437 | Hepatitis C virus subtyping based on sequencing of the C/E1 and NS5B genomic regions in comparison to a commercially available line probe assay. |
Q42988066 | Hepatitis C virus transmission dynamics in injection drug users |
Q42989745 | Hepatitis C virus transmission in hemodialysis units: importance of infection control practices and aseptic technique. |
Q35891292 | Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups |
Q43036833 | Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy |
Q27480276 | Hepatitis C virus-encoded NS2-3 protease: cleavage-site mutagenesis and requirements for bimolecular cleavage |
Q34422738 | Hepatitis C virus. The importance of viral heterogeneity. |
Q43036094 | Hepatitis C virus: From epidemiology and molecular virology to immunobiology |
Q24676346 | Hepatitis C-Z: recent advances |
Q71702111 | Hepatitis C: diagnosis and treatment |
Q42978532 | Hepatitis C: increasing knowledge and unresolved questions |
Q36642065 | Hepatitis C: progress and problems |
Q42987616 | Hepatitis G virus (GBV-C) infection among Brazilian patients with chronic liver disease and blood donors |
Q43040414 | Hepatitis G virus genotypes in a tertiary care centre in southern India |
Q42980940 | Hepatitis G virus infection in hemodialysis patients. |
Q42979853 | Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i.v. drug users in Germany. |
Q36981344 | Hepatitis c virus genotype 4 replication in the hepatocellular carcinoma cell line HepG2/C3A. |
Q45889715 | Hepatitis in haemophilia |
Q38543225 | Hepatitis viruses exploitation of host DNA methyltransferases functions |
Q39537853 | Hepatocellular carcinoma in Sweden: its association with viral hepatitis, especially with hepatitis C viral genotypes |
Q41157467 | Heterogeneity of hepatitis C virus |
Q43040016 | High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. |
Q44224943 | High prevalence of genotype 1 in individuals with hepatitis C in Belo Horizonte, MG |
Q42990073 | High prevalence of hepatitis C virus genotype 6 among certain risk groups in Hong Kong |
Q43046878 | High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon |
Q43047392 | High rate of long-term virological response after a 1-year course of interferon +/- ribavirin in chronic hepatitis C relapsers. Results of a 191 patients randomized trial |
Q40685050 | High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression |
Q46478778 | History of viral hepatitis: a tale of dogmas and misinterpretations |
Q27481388 | Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus |
Q36255746 | Identification of HCV genotypes in HCV infected blood donors |
Q27477460 | Identification of a Naturally Occurring Recombinant Genotype 2/6 Hepatitis C Virus |
Q39829773 | Identification of hepatitis C virus subtype 2c by sequencing analysis in patients from Córdoba, Argentina |
Q42990039 | Identification of in vivo interaction between Hepatitis C Virus core protein and 5' and 3' UTR RNA. |
Q42995338 | Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus. |
Q45750923 | Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection |
Q59200582 | Immunopathogenesis of hepatitis C virus infection |
Q34005309 | Immunopathogenesis of viral hepatitis |
Q37929753 | Impact of HCV genetic differences on pathobiology of disease. |
Q26801381 | Impact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infection |
Q42988876 | Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma. |
Q42979845 | Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA. |
Q39037138 | Impacts and shortcomings of genetic clustering methods for infectious disease outbreaks. |
Q38193551 | Importance of HCV genotype 1 subtypes for drug resistance and response to therapy |
Q36826804 | Important factors in reliable determination of hepatitis C virus genotype by use of the 5' untranslated region |
Q42994314 | Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b undergoing combination therapy |
Q37263558 | In vitro characterization of GSK2485852, a novel hepatitis C virus polymerase inhibitor |
Q40181090 | In vitro infection of immortalized primary hepatocytes by HCV genotype 4a and inhibition of virus replication by cyclosporin |
Q42827965 | In vivo assay for hepatitis C viral serine protease activity using a secreted protein |
Q34870944 | In-vitro model systems to study Hepatitis C Virus |
Q43031115 | Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage |
Q35358973 | Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection |
Q42287334 | Independent factors associated with altered plasma active ghrelin levels in HCV-infected patients |
Q42382462 | Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin. |
Q34970209 | Infection frequency of hepatitis C virus and IL28B haplotypes in Papua New Guinea, Fiji, and Kiribati |
Q42982611 | Infection with GB virus C and hepatitis C virus in hemodialysis patients and blood donors in Beijing |
Q42982624 | Infection with GB virus C/hepatitis G virus in Brazilian hemodialysis and hepatitis patients and asymptomatic individuals |
Q42992334 | Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA. |
Q43033729 | Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy |
Q39141504 | Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians |
Q22010973 | Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research |
Q42993794 | Inquiries on intraspousal transmission of hepatitis C virus: benefits and limitations of genome sequencing and phylogenetic analysis |
Q34333821 | Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients |
Q24290542 | Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation |
Q33788496 | Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group |
Q40961282 | Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis |
Q38870287 | Interferon-induced Parkinsonism in a patient with chronic hepatitis C. |
Q42997948 | Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders |
Q42990093 | Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells |
Q58607034 | Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians |
Q38856008 | Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection |
Q45733855 | Intra-familial transmission of hepatitis B virus in Italy: phylogenetic sequence analysis and amino-acid variation of the core gene |
Q72615665 | Intrafamilial transmission of hepatitis C virus |
Q41809253 | Introduction of an automated system for the diagnosis and quantification of hepatitis B and hepatitis C viruses |
Q27486577 | Investigation of Putative Multisubtype Hepatitis C Virus Infections In Vivo by Heteroduplex Mobility Analysis of Core/Envelope Subgenomes |
Q71867881 | Irish Society of Gastroenterology winter meeting. Dublin, November 1994. Abstracts |
Q29619752 | Isolation of novel virus-like sequences associated with human hepatitis |
Q30307173 | Issues in HIV/Hepatitis C Co-infection |
Q47336884 | Keeping Pace with the Red Queen: Identifying the Genetic Basis of Susceptibility to Infectious Disease. |
Q24648164 | Kinetic and structural analyses of hepatitis C virus polyprotein processing |
Q41904514 | Lack of classic histology should not prevent diagnosis of necrolytic acral erythema |
Q42980799 | Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis |
Q35275932 | Lipid metabolism and HCV infection |
Q42988688 | Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. |
Q42999955 | Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma |
Q73562590 | Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis |
Q42991587 | Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment. |
Q42984513 | Loss of circulating hepatitis C virus in children who developed a persistent carrier state after mother-to-baby transmission |
Q37066393 | Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus |
Q27005739 | Medicinal plants against hepatitis C virus |
Q33539199 | Methods for the differentiation of microorganisms. |
Q28545051 | MicroRNAs as predictor markers for response to interferon treatment of chronic hepatitis C genotype-4 in Egyptian patients |
Q42681703 | Molecular analysis of intraspousal transmission of hepatitis C virus |
Q35660841 | Molecular and contextual markers of hepatitis C virus and drug abuse. |
Q35755597 | Molecular biology and clinical implication of hepatitis C virus |
Q42999755 | Molecular characterisation of HCV genotype 4 isolates circulating in Italy |
Q40061350 | Molecular characterization and epidemic history of hepatitis C virus using core sequences of isolates from Central Province, Saudi Arabia. |
Q35992896 | Molecular characterization of Hepatitis C virus 3a in Peshawar |
Q43033034 | Molecular characterization of hepatitis C virus genotype 2a from the entire sequences of four isolates |
Q34114168 | Molecular epidemiology of Hepatitis C virus genotypes in Khyber Pakhtoonkhaw of Pakistan |
Q42996451 | Molecular epidemiology of an outbreak of HCV in a hemodialysis unit: direct sequencing of HCV-HVR1 as an appropriate tool for phylogenetic analysis |
Q43039877 | Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin |
Q42987165 | Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region |
Q39384230 | Molecular heterogeneity and new subtypes of HCV genotype 4. |
Q36192689 | Molecular methods of hepatitis C genotyping. |
Q42998892 | Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality |
Q33992691 | Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis |
Q71811848 | Monokine production by peripheral whole blood in chronic hepatitis C patients treated with interferon |
Q45768345 | Mother-to-infant transmission of hepatitis C virus: a prospective study |
Q45748378 | Mother-to-infant transmission of hepatitis C virus: molecular evidence of superinfection by homologous virus in children |
Q27469589 | Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns |
Q40637025 | Mutations in the NS5A gene predict response to interferon therapy in Japanese patients with chronic hepatitis C and cirrhosis |
Q21245104 | NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b |
Q36414090 | NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients |
Q73411285 | National Scientific Medical Meeting. 11-12 April 1997. Abstracts |
Q42989273 | Natural history of hepatitis C in thalassemia major: a long-term prospective study |
Q27469708 | Natural variation in translational activities of the 5' nontranslated RNAs of hepatitis C virus genotypes 1a and 1b: evidence for a long-range RNA-RNA interaction outside of the internal ribosomal entry site |
Q33972205 | Nested restriction site-specific PCR to detect and type hepatitis C virus (HCV): a rapid method to distinguish HCV subtype 1b from other genotypes |
Q38044680 | Neurological complications of hepatitis C infection |
Q27478380 | New Natural Intergenotypic (2/5) Recombinant of Hepatitis C Virus |
Q24654270 | New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a |
Q28201488 | New hepatitis viruses: contenders and pretenders |
Q42982178 | New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India |
Q35903826 | Next Generation Sequencing-Based Investigation of Potential Patient-to-Patient Hepatitis C Virus Transmission during Hemodialytic Treatment |
Q42985458 | Non-isotopic detection of hepatitis C virus quasispecies by single strand conformation polymorphism |
Q37032551 | Nonresponse to treatment for hepatitis C: current management strategies |
Q73235078 | Nosocomial transmission of hepatitis C virus |
Q43049546 | Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials |
Q33592762 | Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients |
Q29620681 | Novel insights into hepatitis C virus replication and persistence |
Q42980888 | Nucleotide sequences of the hepatitis C virus core region in patients without anti-core antibody |
Q27480288 | Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients |
Q34896257 | Occurrence of genetic modifications in core, 5'UTR and NS5b of HCV associated with viral response to treatment |
Q34701350 | On hepatitis C virus evolution: the interaction between virus and host towards treatment outcome. |
Q36346527 | Outbreak of hepatitis C virus infection associated with narcotics diversion by an hepatitis C virus-infected surgical technician |
Q42993989 | Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts |
Q27485669 | Partial nucleotide sequencing of six subtype 2c hepatitis C viruses detected in Italy |
Q73429730 | Pathomorphological Characteristics and Pathogenesis of Viral Hepatitis |
Q27478466 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules |
Q27485117 | Patr-A and B, the orthologues of HLA-A and B, present hepatitis C virus epitopes to CD8+ cytotoxic T cells from two chronically infected chimpanzees |
Q42987689 | Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: relation to viral genotype, cryoglobulinemia and response to interferon |
Q34134994 | Pegaferon in hepatitis C: Results of a Multicenter Study |
Q34298265 | Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6. |
Q34499902 | Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant |
Q43000568 | Pharmacodynamics of PEG-IFN alpha differentiate HIV/HCV coinfected sustained virological responders from nonresponders |
Q42979944 | Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology |
Q38974347 | Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients |
Q42977195 | Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients |
Q39464752 | Phylogenetic characterization of genotype 4 hepatitis C virus isolates from Argentina |
Q34172845 | Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa |
Q39018381 | Population dynamics of hepatitis C virus subtypes in injecting drug users on methadone maintenance treatment in China associated with economic and health reform |
Q41907539 | Preclinical characterization of GSK2336805, a novel inhibitor of hepatitis C virus replication that selects for resistance in NS5A |
Q34330704 | Prediction of Sustained Virological Response to Telaprevir-Based Triple Therapy Using Viral Response within 2 Weeks. |
Q33959591 | Prediction of a null response to pegylated interferon α-2b plus ribavirin in patients with high viral load genotype 1b hepatitis C |
Q45351981 | Prediction of efficacy to pegylated interferon-α-2b plus ribavirin in patients with genotype 2 hepatitis C virus using viral response within 2 weeks |
Q43037304 | Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera |
Q42996606 | Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy |
Q42993278 | Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C. |
Q42979085 | Predominance of hepatitis C virus genotype 1b in Bulgaria |
Q27481007 | Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy |
Q44329316 | Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin |
Q42991384 | Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana |
Q42608699 | Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil |
Q42252312 | Prevalence of IL-28B and ITPA genotypes in Chinese Han population infected persistently with hepatitis C virus genotype 6 or HCV-1. |
Q43001719 | Prevalence of hepatitis C virus (HCV) genotypes among positive UAE patients |
Q42999911 | Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil |
Q42979809 | Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia. |
Q42981745 | Prevalence of hepatitis C virus genotypes in southern Italy. |
Q28583333 | Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis |
Q42997576 | Prevalence of hepatitis C virus infection and HCV genotypes among hemophiliacs in the State of Bahia, Northeastern Brazil: analysis of serological and virological parameters |
Q42994014 | Prevalence of intrinsic disorder in the hepatitis C virus ARFP/Core+1/S protein |
Q42994181 | Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease |
Q27485927 | Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini |
Q45732133 | Proposed criteria for classification of new genotypes of mumps virus |
Q31134123 | Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family |
Q42987785 | Prospective virological follow-up of hepatitis C infection in a haemodialysis unit |
Q42987319 | Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa |
Q42984115 | Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot study. |
Q42982502 | Quantitative liver parameters of HCV infection: relation to HCV genotypes, viremia and response to interferon treatment |
Q43674750 | Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C. |
Q42981289 | Rapid and sensitive genotyping of hepatitis C virus by single-strand conformation polymorphism. |
Q42990465 | Rapid genotyping of hepatitis C virus by direct cycle sequencing of PCR-amplified cDNAs and capillary electrophoresis analysis |
Q43036942 | Real-time RT-PCR for quantitation of hepatitis C virus RNA. |
Q37954260 | Recombination in hepatitis C virus |
Q42988498 | Relation between reactivity to the NS-4 region peptides of hepatitis C virus (HCV) and clinical features among patients infected with HCV genotype 1b. |
Q42980957 | Relationship between viral genotype and viral load in patients with chronic hepatitis C. |
Q24814157 | Replicative homeostasis II: influence of polymerase fidelity on RNA virus quasispecies biology: implications for immune recognition, viral autoimmunity and other "virus receptor" diseases |
Q24798257 | Replicative homeostasis: a fundamental mechanism mediating selective viral replication and escape mutation |
Q40620065 | Rescue of infectious classical swine fever and foot-and-mouth disease virus by RNA transfection and virus detection by RT-PCR after extended storage of samples in Trizol |
Q37352979 | Retracted: Genetic diversity in hepatitis C virus (HCV): A brief review |
Q42980410 | Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study |
Q34780196 | Risk factors and genotypes of hepatitis C virus infection in libyan patients |
Q82481674 | Risk factors for hepatitis B and C in multi-transfused patients in Uruguay |
Q33496785 | Risks and benefits of interferon-alpha in the treatment of hepatitis |
Q36246785 | Roles of ITPA and IL28B genotypes in chronic hepatitis C patients treated with peginterferon plus ribavirin |
Q42989444 | Route of infection, liver histology and response to interferon in patients with chronic hepatitis caused by genotype 4 HCV infection in a Western country |
Q42982316 | Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection |
Q34113837 | Routine serologic testing for hepatitis C virus infection should be instituted among dialysis patients |
Q27472939 | Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication |
Q27477965 | Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy |
Q43037280 | Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients |
Q24564165 | Sequence analysis of the core gene of 14 hepatitis C virus genotypes |
Q43041866 | Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak |
Q42981110 | Sequence variation of the hypervariable region in HCV carriers with normal ALT levels: a comparison with symptomatic carriers |
Q27480858 | Sequence variation within a nonstructural region of the hepatitis G virus genome |
Q37040485 | Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes from Patients Infected with Hepatitis C Virus Genotypes 5 and 6. |
Q27477682 | Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland |
Q30732505 | Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product |
Q27485780 | Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay |
Q33961998 | Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay. |
Q42988886 | Serological differentiation between HCV subtypes 1a and 1b by a recombinant immunoblot assay |
Q42984289 | Serotyping and genotyping of hepatitis C virus (HCV) strains in chronic HCV infection. Commission Hepatologie du CREGG. Club de Reflexion des Cabinets de Groupes en GastroEnterologie |
Q42999785 | Serotyping and genotyping of hepatitis C virus in Taiwanese patients with type C chronic liver disease and uraemic patients on maintenance haemodialysis |
Q43033875 | Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C. |
Q35662485 | Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response. |
Q71711461 | Sexual transmission of hepatitis C virus infection |
Q42991917 | Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months? |
Q33853210 | Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus |
Q39455091 | Simplified hepatitis C virus genotyping by heteroduplex mobility analysis |
Q30421625 | Small molecule inhibitors of the hepatitis C virus-encoded NS5A protein |
Q39760409 | Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells |
Q41302293 | Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides |
Q43001848 | Standardized hepatitis C virus RNA panels for nucleic acid testing assays |
Q30361273 | Structure and functions of hepatitis C virus proteins: 15 years after. |
Q43000686 | Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein |
Q41926938 | Study of the hepatitis C virus in the republic of macedonia |
Q27485647 | Study on reliability of commercially available hepatitis C virus antibody tests |
Q27478443 | Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase |
Q27485771 | Subtype 2c of hepatitis C virus is highly prevalent in Italy and is heterogeneous in the NS5A region |
Q27487935 | Subtype analysis of hepatitis C virus in Indonesia on the basis of NS5b region sequences |
Q40627310 | Subtype distribution of hepatitis C virus in Jiangsu, China |
Q43047003 | Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay |
Q42980565 | Superinfection by homotypic virus in hepatitis C virus carriers: studies on patients with post-transfusion hepatitis |
Q27485682 | Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay |
Q30329370 | Susceptibility testing. Viral pathogens. |
Q45422073 | Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee |
Q39673107 | Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors |
Q42988999 | Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia. |
Q92391332 | Taming a beast: lessons from the domestication of hepatitis C virus |
Q27485658 | Tear fluid of hepatitis C virus carriers could be infectious |
Q43041192 | Testing of blood donations for hepatitis C virus |
Q27489040 | The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy |
Q35698428 | The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis |
Q36169070 | The Phylogeographic and Spatiotemporal Spread of HCV in Pakistani Population |
Q35843443 | The Polymerase Chain Reaction: Essential for the Development of Curative Therapy for Hepatitis C |
Q42989109 | The burden of anti-HCV genotye-4 positivity in renal transplant recipients: 8 years follow-up. |
Q36892181 | The epidemiology of hepatitis C infection in the United States |
Q37276135 | The first complete genome sequence of HCV-1a from Pakistan and a phylogenetic analysis with complete genomes from the rest of the world |
Q28654353 | The global epidemiology of hepatocellular carcinoma: present and future |
Q27480848 | The hepatitis C virus NS4A protein: interactions with the NS4B and NS5A proteins |
Q35122636 | The hepatitis C virus persistence: how to evade the immune system? |
Q34709019 | The impact of polymorphisms in STAT6 on treatment outcome in HCV infected Taiwanese Chinese |
Q42223133 | The intrinsic disorder status of the human hepatitis C virus proteome |
Q34210660 | The molecular biology of hepatitis C virus. Genotypes and quasispecies |
Q42993584 | The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a. |
Q73590296 | The prevalence of HCV infection in a cohort of pregnant women, the related risk factors and the possibility of vertical transmission |
Q42985942 | The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease |
Q41574241 | The quasispecies of hepatitis C virus and the host immune response |
Q35937739 | The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV |
Q27470086 | Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants |
Q27480747 | Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients |
Q43040602 | Transcription-mediated amplification linked to line probe assay as a routine tool for HCV typing in clinical laboratories |
Q41462997 | Transmission of hepatitis C virus associated with surgical procedures - New Jersey 2010 and Wisconsin 2011. |
Q24800686 | Transmission of human hepatitis C virus from patients in secondary cells for long term culture |
Q34991688 | Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 2: hepatitis C virus). |
Q42984463 | Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies. |
Q27485998 | Two hepatitis C virus glycoprotein E2 products with different C termini |
Q42982643 | Understanding the structural and energetic basis of inhibitor and substrate bound to the full-length NS3/4A: insights from molecular dynamics simulation, binding free energy calculation and network analysis |
Q34163394 | Update on different aspects of HCV variability: focus on NS5B polymerase |
Q38584271 | Update on the Development of Anti-Viral Agents Against Hepatitis C. |
Q35960876 | Use and interpretation of HCV diagnostic tests in the clinical setting |
Q27472773 | Use of a commercially available line probe assay for genotyping of hepatitis C virus 5a strains |
Q27480326 | Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region |
Q39192032 | Usefulness and limitation of phylogenetic analysis for hepatitis C virus core region: application to isolates from Egyptian and Yemeni patients |
Q43049593 | Vaccination against hepatitis C virus infection: miles to go before we sleep |
Q29615899 | Vaccination of chimpanzees against infection by the hepatitis C virus |
Q40397337 | Variability of hepatitis C virus |
Q36027172 | Variability of the preC/C region of hepatitis B virus genotype A from a South African cohort predominantly infected with HIV. |
Q43038843 | Variant analysis and immunogenicity prediction of envelope gene of HCV strains from China |
Q27478062 | Viral Determinants of Resistance to Treatment in Patients with Hepatitis C |
Q34549186 | Viral hepatitis a to e in South mediterranean countries |
Q33809445 | Viral heterogeneity of the hepatitis C virus |
Q71804793 | Virology of hepatitis C virus |
Q36034899 | What you need to know about GB virus C. |
Q42982882 | cDNA sequencing of the 5' noncoding region (5' NCR) to determine hepatitis C genotypes in patients with chronic hepatitis C. |
Search more.